The malignant progression effects of regorafenib in human colon cancer cells

Journal of Medical Investigation

Volumn 62, Issue 3, 2015, Pages 195-198

  Tomida, Chisato ^a   Aibara, Kana ^a   Yamagishi, Naoko ^a   Yano, Chiaki ^a   Nagano, Hikaru ^c   Abe, Tomoki ^a   Ohno, Ayako ^a   Hirasaka, Katsuya ^b   Nikawa, Takeshi ^a   Teshima Kondo, Shigetada ^a  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

^b NAGASAKI UNIVERSITY   (Japan)

^c SAGAMI WOMEN'S UNIVERSITY   (Japan)

Author keywords

Angiogenesis inhibitor; Colon cancer cells; Malignant phenotype; Regorafenib; VEGF receptor tyrosine kinase inhibitor

Indexed keywords

REGORAFENIB; VASCULOTROPIN RECEPTOR; CARBANILAMIDE DERIVATIVE; PYRIDINE DERIVATIVE;

APOPTOSIS; ARTICLE; CANCER CELL; CANCER GROWTH; CANCER RESISTANCE; CELL ACTIVATION; CELL INVASION; CELL MIGRATION; COLON CANCER CELL; CONTROLLED STUDY; DRUG EFFECT; DRUG TARGETING; HCT116 CELL LINE; HUMAN; HUMAN CELL; INTRACELLULAR SIGNALING; PHENOTYPE; PROTEIN DEPLETION; PROTEIN TARGETING; ANTAGONISTS AND INHIBITORS; CELL MOTION; COLONIC NEOPLASMS; DISEASE COURSE; DRUG RESISTANCE; HCT 116 CELL LINE; PATHOLOGY; TUMOR INVASION;

APOPTOSIS; CELL MOVEMENT; COLONIC NEOPLASMS; DISEASE PROGRESSION; DRUG RESISTANCE, NEOPLASM; HCT116 CELLS; HUMANS; NEOPLASM INVASIVENESS; PHENYLUREA COMPOUNDS; PYRIDINES; RECEPTORS, VASCULAR ENDOTHELIAL GROWTH FACTOR;

EID: 84942023129     PISSN: 13431420     EISSN: 13496867     Source Type: Journal    
DOI: 10.2152/jmi.62.195     Document Type: Article

References (25)

1. Saika K, Sobue T: Cancer statistics in the world. Gan To Kagaku Ryoho 40: 2475-2480, 2013.
2. Kohne CH, Lenz HJ: Chemotherapy with targeted agents for the treatment of metastatic colorectal cancer. The oncologist 14: 478-488, 2009.
3. Mitchell EP: Targeted therapy for metastatic colorectal cancer: role of aflibercept. Clin Colorectal Cancer 12: 73-85, 2013.
4. Fakih M: The evolving role of VEGF-targeted therapies in the treatment of metastatic colorectal cancer. Expert Rev Anticancer Ther 13: 427-438, 2013.
5. Martinelli E, Troiani T, Morgillo F, OrdituraM, De Vita F, Belli G, Ciardiello F: Emerging VEGF-receptor inhibitors for colorectal cancer. Expert Opin Emerg Drugs 18: 25-37, 2013.
6. Carter NJ: Regorafenib: a review of its use in previously treated patients with progressive metastatic colorectal cancer. Drugs Aging 31(1): 67-78, 2014.
7. Bergers G, Hanahan D: Modes of resistance to anti-angiogenic therapy. Nat Rev Cancer 8: 592-603, 2008.
8. Ellis LM, Hicklin DJ: Pathways mediating resistance to vascular endothelial growth factor-targeted therapy. Clin Cancer Res 14: 6371-6375, 2008.
9. Ebos JM, Lee CR, Kerbel RS: Tumor and host-mediated pathways of resistance and disease progression in response to antiangiogenic therapy. Clin Cancer Res 15: 5020-5025, 2009.
10. Fan F, Wey JS, McCartyMF, Belcheva A, LiuW, Bauer TW, Somcio RJ, Wu Y, Hooper A, Hicklin DJ, Ellis LM: Expression and function of vascular endothelial growth factor receptor 1 on human colorectal cancer cells. Oncogene 24: 2647-2653, 2005.
11. Bachelder RE, Crago A, Chung J, Wendt MA, Shaw LM, Robinson G, Mercurio AM: Vascular endothelial growth factor is an autocrine survival factor for neuropilin-expressing breast carcinoma cells. Cancer Res 61: 5736-5740, 2001.
12. Frank NY, Schatton T, KimS, Zhan Q, Wilson BJ, Ma J, Saab KR, Osherov V, Widlund HR, Gasser M, Waaga-Gasser AM, Kupper TS, Murphy GF, Frank MH: VEGFR-1 expressed by malignant melanoma-initiating cells is required for tumor growth. Cancer Res 71: 1474-1485, 2011.
13. Fan F, Samuel S, Gaur P, Lu J, Dallas NA, Xia L, Bose D, Ramachandran V, Ellis LM: Chronic exposure of colorectal cancer cells to anti-VEGF mAb promotes compensatory pathways that mediate tumor cell migration. British J Cancer 104: 1270-1277, 2011.
14. Yamagishi N, Teshima-Kondo S, Masuda K, Nishida K, Kuwano Y, Dang DT, Dang LH, Nikawa T, Rokutan K: Chronic inhibition of tumor cell-derived VEGF enhances the malignant phenotype of colorectal cancer cells. BMC Cancer 13: 229, 2013.
15. Tomida C, Yamagishi N, Aibara K, Yano C, Uchida T, Abe T, Ohno A, Hirasaka K, Nikawa T, Teshima-Kondo S: Chronic exposure of VEGF inhibitors promotes the malignant phenotype of colorectal cancer cells. J Med Invest 62: 75-79, 2015.
16. Ebos JM, Lee CR, Cruz-Munoz W, Bjarnason GA, Christensen JG, Kerbel RS: Accelerated metastasis after short-term treatment with a potent inhibitor of tumor angiogenesis. Cancer Cell 15: 232-239, 2009.
17. Pàez-RibesM, Allen E, Hudock J, Takeda T, Okuyama H, Viñals F, Inoue M, Bergers G, Hanahan D, Casanovas O: Antiangiogenic therapy elicits malignant progression of tumors to increased local invasion and distant metastasis. Cancer Cell 15: 220-231, 2009.
18. Semenza GL: Targeting HIF-1 for cancer therapy. Nat Rev Cancer 3: 721-732, 2003.
19. Semenza GL: Hypoxia-inducible factors in physiology and medicine. Cell 148: 399-408, 2012.
20. Bottsford-Miller JN, Coleman RL, Sood AK: Resistance and escape from antiangiogenesis therapy: clinical implications and future strategies. J Clin Oncol 30: 4026-4034, 2012.
21. Lu KV, Chang JP, Parachoniak MM, Aghi MK, Meyronet D, Isachenko N, Fouse SD, Philips JJ, Cheresh DA, Park M, Bergers G: VEGF inhibits Tumor Cell Invasion and Mesenchymal Transition through a MET/VEGFR2 Complex. Cancer Cell 22: 21-35, 2012.
22. Lu KV, Chang JP, Parachoniak CA, Pandika MM, Aghi MK, Meyronet D, Isachenko N, Fouse SD, Phillips JJ, Cheresh DA, Park M, Bergers G: VEGF inhibits tumor cell invasion and mesenchymal transition through a MET/VEGFR2 complex. Cancer Cell 22: 21-35, 2012.
23. Sennino B, Ishiguro-Oonuma T, Wei Y, Naylor RM, Williamson CW, Bhagwandin V, Tabruyn SP, You WK, Chapman HA, Christensen JG, Aftab DT, McDonald DM: Suppression of tumor invasion and metastasis by concurrent inhibition of c-Met and VEGF signaling in pancreatic neuroendocrine tumors. Cancer Discov 2: 270-287, 2012.
24. Vakkalanka BK, Rini BI: Targeted therapy in renal cell carcinoma. Curr Opin Urol 18: 481-487, 2008.
25. Escudier B, Cosaert J, Pisa P: Bevacizumab: direct anti-VEGF therapy in renal cell carcinoma. Expert Rev Anticancer Ther 8: 1545-1557, 2008.